1.
Tonder M, Eisele G, Weiss T, Hofer S, Seystahl K, Valavanis A, et al. Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. AO [Internet]. 2014 Oct. 1 [cited 2026 Jun. 18];53(10):1436-40. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/27421